Movement Disorders :Neurology

Publication subTitle :Neurology

Author: Marsden   C. David;Fahn   Stanley  

Publisher: Elsevier Science‎

Publication year: 2013

E-ISBN: 9781483163147

P-ISBN(Paperback): 9780407022959

P-ISBN(Hardback):  9780407022959

Subject: R742.5 paralysis agitans syndrome

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Description

Neurology, Volume 2: Movement Disorders is a part of an international series of critical reviews of topics in neurology. This volume focuses on Parkinsonism and dyskinesia, a condition characterized by abnormal involuntary movements.
Organized into 18 chapters, this book first elucidates the problems, causes, pathology, brain neurotransmitter changes and receptors, depression, dementia, fluctuations of disability, and treatment of Parkinson's disease. Subsequent chapters then explore the problems, controversies, and surgical approaches involved in certain dyskinesias. The role of dopamine receptors in movement disorders is also explored.
This book will be valuable to neurologists-in-training, as well as to those in research field or in practice in this field of interest. The book's clinical content will help in the management of patients with movement disorders.

Chapter

Front Cover

pp.:  1 – 4

Movement Disorders

pp.:  4 – 5

Copyright Page

pp.:  5 – 12

Table of Contents

pp.:  12 – 16

Chapter 2. The cause of Parkinson's disease

pp.:  23 – 40

Chapter 3. Pathology of Parkinson's disease

pp.:  40 – 56

Chapter 4. Brain neurotransmitter changes in Parkinson's disease

pp.:  56 – 74

Chapter 5. Brain neurotransmitter receptors in Parkinson's disease

pp.:  74 – 90

Chapter 6. Depression and dementia in Parkinson's disease

pp.:  90 – 111

Chapter 7. Fluctuations of disability in Parkinson's disease –clinical aspects

pp.:  111 – 138

Chapter 8. Fluctuations of disability in Parkinson's disease: pathophysiology

pp.:  138 – 161

Chapter 9. Treatment of advanced Parkinson's disease with dopamine agonists

pp.:  161 – 181

Chapter 10. Deprenyl in Parkinson's disease

pp.:  181 – 189

Chapter 11. Parkinsonism, system degenerations and autonomic failure

pp.:  189 – 206

Chapter 12. Problems in dyskinesias

pp.:  206 – 211

Chapter 13. The nosology and pathophysiology of myoclonus

pp.:  211 – 264

Chapter 14. Clinical controversies in tardive dyskinesia

pp.:  264 – 278

Chapter 15. Controversies in animal models of tardive dyskinesia

pp.:  278 – 292

Chapter 16. Care of patients and families with Huntington's disease

pp.:  292 – 306

Chapter 17.1. Surgical approaches to the dyskinesias: foreword

pp.:  306 – 307

Chapter 17.2. Surgical approach to tremor

pp.:  307 – 315

Chapter 17.3. Surgical approach to dystonia

pp.:  315 – 323

Chapter 17.4. Surgical treatment of spasmodic torticollis

pp.:  323 – 330

Chapter 17.5. Peripheral versus central surgical approach for the treatment of spasmodic torticollis

pp.:  330 – 334

Chapter 17.6. Surgical approach to blepharospasm: nerve thermolysis

pp.:  334 – 337

Chapter 17.7. The surgical management of essential blepharospasm

pp.:  337 – 345

Chapter 17.8. Surgical approach to hemifacial spasm: microvascular decompression

pp.:  345 – 349

Chapter 17.9. Cerebellar and deep brain stimulation in movement disorders

pp.:  349 – 360

Chapter 17.10. Surgical approaches to the dyskinesias: afterword

pp.:  360 – 363

Chapter 18.1. Dopamine receptors in movement disorders

pp.:  363 – 371

Chapter 18.2. Interpretation of radioactive ligand binding to cerebral dopamine receptors

pp.:  371 – 384

Index

pp.:  384 – 395

The users who browse this book also browse


No browse record.